Harbour Investments’s Privia Health PRVA Stock Holding History

Harbour Investments’s Portfolio PRVA Stock Details PRVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2	Closed	–	–	3920
2021 Q2	$0	Buy	+2	New	+$74	﹤0.01%	3917

Other funds holding PRVA

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

SIG

Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Harbour Investments's PRVA Position: Q3 2021 in Review

Harbour Investments sold out of Privia Health (PRVA) in Q3 2021, closing a stake of 2 shares.

Harbour Investments first reported a position in PRVA in Q2 2021 and held it in 1 quarter. The position peaked at $0 in Q2 2021. 90 funds tracked by Wall St. Rank hold PRVA as of Q3 2021.

Harbour Investments reported no remaining Privia Health position as of Q3 2021 after selling out during the quarter.
Harbour Investments sold 2 Privia Health shares in Q3 2021.
Harbour Investments first reported a position in Privia Health in Q2 2021 and held it in 1 quarter.
Harbour Investments's Privia Health position peaked at $0 in Q2 2021.
90 funds tracked by Wall St. Rank held Privia Health as of Q3 2021.

Based on Harbour Investments's 13F filing for Q3 2021, filed 15 Nov 2021.